Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Kolditz

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Der Pneumologe|July 19, 2021
[Prevention by vaccination of adult patients with pulmonary diseases]Carolin Dodt, Mathias W Pletz, Martin Kolditz
Seminars in Respiratory and Critical Care Medicine|December 14, 2016
Severity Assessment and the Immediate and Long-Term Prognosis in Community-Acquired PneumoniaMartin Kolditz, Dionne Braeken, Santiago Ewig, et al.
Infection|February 3, 2020
Prognostic value of blood pressure drops during the first 24 h after hospital admission for risk stratification of community-acquired pneumonia: a retrospective cohort studyBernhard Schulte-Hubbert, Nils Meiswinkel, Ulrike Kutschan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2018
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on the Incidence of All-cause Pneumonia in Adults Aged ≥60 Years: A Population-based, Retrospective Cohort StudyMartin Kolditz, Jochen Schmitt, Mathias W Pletz, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 29, 2010
Combined vasomodulatory therapy for severe pulmonary hypertension in chronic hypersensitivity pneumonitisDirk Steffen Koschel, Martin Kolditz, Gert Höeffken, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2019
Reply to Theilacker et alMartin Kolditz, Jochen Schmitt, Mathias W Pletz, et al.
Wiener Klinische Wochenschrift|February 21, 2006
Successful switch from long-term intravenous iloprost to non-invasive combination therapy in idiopathic pulmonary arterial hypertensionMichael Halank, Martin Kolditz, Christian Opitz, et al.
BMC Pulmonary Medicine|December 23, 2024
Trans-bronchial forceps biopsy for COVID-19 related diffuse parenchymal lung abnormalitiesJanina Kleymann, Sascha Brückmann, Simona Langner, et al.
The European Respiratory Journal|May 26, 2022
Benefit of monoclonal antibodies in early treatment of COVID-19 after lung transplantation: a retrospective analysis in two centresJens Gottlieb, Martin Kolditz, Nils Gade, et al.
ERJ Open Research|June 20, 2023
Validation of the qSOFA and CRB-65 in SARS-CoV-2-infected community-acquired pneumoniaTina Richter, Falko Tesch, Jochen Schmitt, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Der Pneumologe|July 19, 2021
[Prevention by vaccination of adult patients with pulmonary diseases]Carolin Dodt, Mathias W Pletz, Martin Kolditz
Seminars in Respiratory and Critical Care Medicine|December 14, 2016
Severity Assessment and the Immediate and Long-Term Prognosis in Community-Acquired PneumoniaMartin Kolditz, Dionne Braeken, Santiago Ewig, et al.
Infection|February 3, 2020
Prognostic value of blood pressure drops during the first 24 h after hospital admission for risk stratification of community-acquired pneumonia: a retrospective cohort studyBernhard Schulte-Hubbert, Nils Meiswinkel, Ulrike Kutschan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2018
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on the Incidence of All-cause Pneumonia in Adults Aged ≥60 Years: A Population-based, Retrospective Cohort StudyMartin Kolditz, Jochen Schmitt, Mathias W Pletz, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 29, 2010
Combined vasomodulatory therapy for severe pulmonary hypertension in chronic hypersensitivity pneumonitisDirk Steffen Koschel, Martin Kolditz, Gert Höeffken, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2019
Reply to Theilacker et alMartin Kolditz, Jochen Schmitt, Mathias W Pletz, et al.
Wiener Klinische Wochenschrift|February 21, 2006
Successful switch from long-term intravenous iloprost to non-invasive combination therapy in idiopathic pulmonary arterial hypertensionMichael Halank, Martin Kolditz, Christian Opitz, et al.
BMC Pulmonary Medicine|December 23, 2024
Trans-bronchial forceps biopsy for COVID-19 related diffuse parenchymal lung abnormalitiesJanina Kleymann, Sascha Brückmann, Simona Langner, et al.
The European Respiratory Journal|May 26, 2022
Benefit of monoclonal antibodies in early treatment of COVID-19 after lung transplantation: a retrospective analysis in two centresJens Gottlieb, Martin Kolditz, Nils Gade, et al.
ERJ Open Research|June 20, 2023
Validation of the qSOFA and CRB-65 in SARS-CoV-2-infected community-acquired pneumoniaTina Richter, Falko Tesch, Jochen Schmitt, et al.
Pageof 7